The quick version is easy to repeat; the useful version takes longer. Potent sedating medications are often used on agitated people with dementia in long-term care. What...

The quick version is easy to repeat; the useful version takes longer. Potent sedating medications are often used on agitated people with dementia in long-term care. What follows separates what is established from what is promising, and marks the places where the evidence is still thin.
The evidence base is uneven by design. Some questions attract large trials and detailed reporting; others rely on small studies, registry data or the experience of clinicians. That imbalance does not make the weaker evidence useless, but it does mean that confident summaries should be read with care, especially when they travel beyond the population that was studied.
The larger lesson is about how health policy travels: promises move fast, capacity moves slowly, and trust moves in both directions. Anyone following this story should keep an eye on implementation, because that is where the real test will be recorded. It is worth keeping the distinction between a promising signal and a proven result, because the gap between the two is where most disappointment lives.